These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 32882214)

  • 1. Norquetiapine blocks the human cardiac sodium channel Na
    Kim DH; Park KS; Park SH; Hahn SJ; Choi JS
    Eur J Pharmacol; 2020 Oct; 885():173532. PubMed ID: 32882214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of norquetiapine, the active metabolite of quetiapine, on cloned hERG potassium channels.
    Lee HJ; Choi JS; Choi BH; Hahn SJ
    Neurosci Lett; 2018 Jan; 664():66-73. PubMed ID: 29133173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of inhibition by chlorpromazine of the human pain threshold sodium channel, Na
    Lee SJ; Kim DH; Hahn SJ; Waxman SG; Choi JS
    Neurosci Lett; 2017 Feb; 639():1-7. PubMed ID: 28017662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trifluoperazine blocks the human cardiac sodium channel, Na
    Kim DH; Lee SJ; Hahn SJ; Choi JS
    Biochem Biophys Res Commun; 2016 Oct; 479(3):584-589. PubMed ID: 27666479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blocking characteristics of hERG, hNav1.5, and hKvLQT1/hminK after administration of the novel anti-arrhythmic compound AZD7009.
    Persson F; Carlsson L; Duker G; Jacobson I
    J Cardiovasc Electrophysiol; 2005 Mar; 16(3):329-41. PubMed ID: 15817095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of hERG and hNav1.5 channel blockade by sulcardine sulfate, a novel anti-arrhythmic compound.
    Chen W; Gan L; Wang Y
    Eur J Pharmacol; 2019 Feb; 844():130-138. PubMed ID: 30529471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quetiapine and its metabolite norquetiapine: translation from in vitro pharmacology to in vivo efficacy in rodent models.
    Cross AJ; Widzowski D; Maciag C; Zacco A; Hudzik T; Liu J; Nyberg S; Wood MW
    Br J Pharmacol; 2016 Jan; 173(1):155-66. PubMed ID: 26436896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potent Inactivation-Dependent Inhibition of Adult and Neonatal NaV1.5 Channels by Lidocaine and Levobupivacaine.
    Elajnaf T; Baptista-Hon DT; Hales TG
    Anesth Analg; 2018 Sep; 127(3):650-660. PubMed ID: 29958221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proarrhythmic mechanisms of the common anti-diarrheal medication loperamide: revelations from the opioid abuse epidemic.
    Kang J; Compton DR; Vaz RJ; Rampe D
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Oct; 389(10):1133-7. PubMed ID: 27530870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular determinants of state-dependent block of voltage-gated sodium channels by pilsicainide.
    Desaphy JF; Dipalma A; Costanza T; Bruno C; Lentini G; Franchini C; George A; Conte Camerino D
    Br J Pharmacol; 2010 Jul; 160(6):1521-33. PubMed ID: 20590641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effects of hesperetin on Nav1.5 channels stably expressed in HEK 293 cells and on the voltage-gated cardiac sodium current in human atrial myocytes.
    Wang H; Wang HF; Zhang H; Wang C; Chen YF; Ma R; Xiang JZ; Du XL; Tang Q
    Acta Pharmacol Sin; 2016 Dec; 37(12):1563-1573. PubMed ID: 27694909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Block of human cardiac sodium channels by lacosamide: evidence for slow drug binding along the activation pathway.
    Wang GK; Wang SY
    Mol Pharmacol; 2014 May; 85(5):692-702. PubMed ID: 24563546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of the antipsychotic drug quetiapine and its metabolite norquetiapine on acute inflammation, memory and anhedonia.
    Jaehne EJ; Corrigan F; Toben C; Jawahar MC; Baune BT
    Pharmacol Biochem Behav; 2015 Aug; 135():136-44. PubMed ID: 26047769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing use-dependent inhibition of the cardiac Na(+/-) current (I(Na)) in the PatchXpress automated patch clamp.
    Penniman JR; Kim DC; Salata JJ; Imredy JP
    J Pharmacol Toxicol Methods; 2010; 62(2):107-18. PubMed ID: 20601018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cardiac sodium current Na(v)1.5 is functionally expressed in rabbit bronchial smooth muscle cells.
    Bradley E; Webb TI; Hollywood MA; Sergeant GP; McHale NG; Thornbury KD
    Am J Physiol Cell Physiol; 2013 Aug; 305(4):C427-35. PubMed ID: 23784541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. State-dependent block of human cardiac hNav1.5 sodium channels by propafenone.
    Edrich T; Wang SY; Wang GK
    J Membr Biol; 2005 Sep; 207(1):35-43. PubMed ID: 16463141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Na+ channel blocker, pilsicainide, on HERG current expressed in HEK-293 cells.
    Wu LM; Orikabe M; Hirano Y; Kawano S; Hiraoka M
    J Cardiovasc Pharmacol; 2003 Sep; 42(3):410-8. PubMed ID: 12960687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human embryonic stem cell derived cardiac myocytes detect hERG-mediated repolarization effects, but not Nav1.5 induced depolarization delay.
    Qu Y; Gao B; Fang M; Vargas HM
    J Pharmacol Toxicol Methods; 2013; 68(1):74-81. PubMed ID: 23518063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular basis of the inhibition of the fast inactivation of voltage-gated sodium channel Nav1.5 by tarantula toxin Jingzhaotoxin-II.
    Huang Y; Zhou X; Tang C; Zhang Y; Tao H; Chen P; Liu Z
    Peptides; 2015 Jun; 68():175-82. PubMed ID: 25817910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of the cardiac Na⁺ channel α-subunit Nav1.5 by propofol and dexmedetomidine.
    Stoetzer C; Reuter S; Doll T; Foadi N; Wegner F; Leffler A
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Mar; 389(3):315-25. PubMed ID: 26667357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.